Eli Lilly is investing $27 billion in U.S. manufacturing to expand drug production and secure future supply. The company will ...

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed yesterday at $901.80. See what stocks are ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other high growth mega cap stocks. Exactly 5 years ago, the world struggled to deal with a ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other high growth mega cap stocks. Exactly 5 years ago, the world struggled to deal with a ...

SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches ...

Lilly is acquiring all commercial and intellectual property rights to Organovo's FXR program for worldwide development. Organovo is a clinical stage biotechnology company that is developing drugs that ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other top stocks to buy according to sustainable insight capital management. Sustainable Insight ...